FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15219811000001109: Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1305701000001111 Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1305721000001116 Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Is a Dobutamine 250mg/50ml solution for infusion vials true Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Has active ingredient Dobutamine true Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Has excipient Sodium metabisulfite false Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dobutamine true Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Has specific active ingredient Dobutamine hydrochloride true Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Has basis of strength substance Dobutamine true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) 1 vial Has AMP True Dobutamine 250mg/50ml solution for infusion vials (hameln pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start